Rhinitis medicamentosa
Authors:
- Martyna ByrskaMBMartyna Byrska
- Hanna Barska-KobylińskaHBHanna Barska-Kobylińska
- Marta JanuraMJMarta Janura
- Maja WeimannMWMaja Weimann
- Grzegorz PrzywaraGPGrzegorz Przywara
- Oliwia BiegańskaOBOliwia Biegańska
- Emilia BiczakEBEmilia Biczak
- Ewa Katarzyna MalakaEMEwa Katarzyna Malaka
- Marlena ZubiakMZMarlena Zubiak
- Sara LangnerSLSara Langner
Open Access
- 3 May 2025
- journal article
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 81, 60044
Abstract
Introduction:Rhinitis medicamentosa (RM) is a chronic inflammatory condition of the nasal mucosa caused by excessive use of topical nasal decongestants. This leads to tachyphylaxis, increased vascular permeability, chronic inflammation, and structural changes in the nasal mucosa, resulting in medication dependence and persistent nasal congestion. Study Objective: This study aims to discuss the mechanisms underlying RM, its clinical consequences, diagnostic methods, and therapeutic strategies. Additionally, it highlights the importance of patient education and healthcare professional awareness in preventing RM and reducing its prevalence. Materials and Methods: A comprehensive literature review was conducted, analysing current scientific research on RM, including its pathophysiology, diagnostics and treatment methods. Additionally, the review explored the systemic implications, association with addiction, and the importance of prevention and education in managing the condition. Conclusions: There is a need for better education for both patients and healthcare professionals regarding RM. A key element of RM prevention is informing patients about the importance of limiting the use of these medications to a maximum of 5–7 days. Furthermore, further research is necessary to develop more effective therapeutic methods, including the potential use of alternative substances such as xylitol or hyaluronic acid in the regeneration of the nasal mucosa.Keywords
This publication has 25 references indexed in Scilit:
- Rhinitis medicomentosa and substance addictionEuropean Archives of Oto-Rhino-Laryngology, 2024
- Xylitol treats nasal mucosa in rhinitis medicamentosa: an experimental rat model studyEuropean Archives of Oto-Rhino-Laryngology, 2019
- The in vitro mucolytic effect of xylitol and dornase alfa on chronic rhinosinusitis mucusInternational Forum of Allergy & Rhinology, 2017
- Self-Medication in Persistent Rhinitis: Overuse of Decongestants in Half of the PatientsThe Journal of Allergy and Clinical Immunology: In Practice, 2014
- Intranasal sodium hyaluronate on the nasal cytology of patients with allergic and nonallergic rhinitisInternational Forum of Allergy & Rhinology, 2013
- Xylitol nasal irrigation in the management of chronic rhinosinusitis: A pilot studyThe Laryngoscope, 2011
- Other Causes of Rhinitis: Mixed Rhinitis, Rhinitis Medicamentosa, Hormonal Rhinitis, Rhinitis of the Elderly, and Gustatory RhinitisImmunology and Allergy Clinics of North America, 2011
- Rhinitis medicamentosa: what an otolaryngologist needs to knowEuropean Archives of Oto-Rhino-Laryngology, 2008
- Rhinitis medicamentosa and the stuffy noseJournal of Allergy and Clinical Immunology, 2006
- Safety Review of Benzalkonium Chloride Used as a Preservative in Intranasal Solutions: An Overview of Conflicting Data and OpinionsOtolaryngology–Head and Neck Surgery, 2004